Table 3 Promoter methylation at DAPK, MGMT, hMLH1, OR beta, and p16 at week 0 and week 6 in 10 of the group 1 patients.
| Week 0 (n = 10) (No (%)) | Week 6 (n = 10) (No (%)) | |
|---|---|---|
| DAPK | 2 (20) | 1 (10) |
| MGMT | 0 | 2 (20) |
| hMLH1 | 1 (10) | 1 (10) |
| OR beta | 6 (60) | 5 (50) |
| p16 | 0 | 0 |
| E‐cadherin | 5 (50) | 2 (20) |
DAPK, DAP kinase; MGMT, O6‐methyl‐guanine methyltransferase; hMLH1, human Mut L homologue; OR beta, oestrogen receptor beta.